Cargando…
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although...
Autores principales: | Rahman, Ahsab, Tabassum, Tahani, Araf, Yusha, Al Nahid, Abdullah, Ullah, Md. Asad, Hosen, Mohammad Jakir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062941/ https://www.ncbi.nlm.nih.gov/pubmed/33891272 http://dx.doi.org/10.1007/s11033-021-06358-1 |
Ejemplares similares
-
Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges
por: Tabassum, Tahani, et al.
Publicado: (2022) -
COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression
por: Tabassum, Tahani, et al.
Publicado: (2021) -
Prospective selected biomarkers in COVID-19 diagnosis and treatment
por: Tabassum, Tahani, et al.
Publicado: (2021) -
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies
por: Ahmed, Nafisa, et al.
Publicado: (2022) -
COVID-19 in Bangladesh: Wave-centric assessments and mitigation measures for future pandemics
por: Tabassum, Tahani, et al.
Publicado: (2023)